newsfilter
← Latest News
PR Newswire·

Compugen to Participate in Upcoming Investor Conferences

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...